SCHEMBL18392292

SCHEMBL18392292

Cc1[nH]c2ccccc2c1-c1c(-c2c[nH]c3ccc(Br)cc23)c(=O)c1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ SI P14410 1/20 0.48
▸ MGAM2 Q2M2H8 1/20 0.48
▸ CAMK2D Q13557 2/20 0.45
▸ S100A4 P26447 1/20 0.43
▸ CCNB2 O95067 3/20 0.43
▸ CDK1 P06493 3/20 0.43
▸ CCNB1 P14635 3/20 0.43
▸ CCNB3 Q8WWL7 3/20 0.43
▸ CCNE2 O96020 2/20 0.43
▸ CCNE1 P24864 2/20 0.43
▸ CDK2 P24941 2/20 0.43
▸ CDK4 P11802 1/20 0.43
▸ CCND1 P24385 1/20 0.43
▸ LMNA P02545 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ GABRA1 P14867 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ GABRA3 P34903 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18392402 0.87 CCR6 (0.47) CAMK2DCCNB2CDK1CCNB1CCNB3
SCHEMBL18392166 0.86 S100A4 (0.54) MGAMGAASIMGAM2CAMK2D
SCHEMBL18392216 0.85 PTGS2 (0.48) GAACAMK2DS100A4CCNB2CDK1
SCHEMBL18392173 0.84 ABCG2 (0.54) CCNB2CDK1CCNB1CCNB3LMNA
SCHEMBL20365540 0.83 PRKCB (0.39) GABRA1GABRB1GABRA3GABRB2KMT2A
SCHEMBL18392217 0.78 GSK3B (0.47) CAMK2DCCNB2CDK1CCNB1CCNB3
SCHEMBL18392175 0.77 CCR6 (0.58) GAALMNAHPGDKMT2AHSD17B10
SCHEMBL30277945 0.76 LMNA (0.53) MGAMGAASIMGAM2CAMK2D
SCHEMBL18392203 0.75 MEN1 (0.54) MGAMGAASIMGAM2CAMK2D
SCHEMBL29094072 0.75 PTGS2 (0.49) MGAMGAASIMGAM2CAMK2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3319940-B1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME UNIV BRAUNSCHWEIG TECH (DE) 2019-05-29 — — EP disclosed
EP-3319940-B1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME UNIV BRAUNSCHWEIG TECH (DE) 2019-05-29 — — EP disclosed
US-10287271-B2 Indole compounds having antiprotozoal activity and its use as well as methods for producing the same TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2019-05-14 — — US disclosed
US-10287271-B2 Indole compounds having antiprotozoal activity and its use as well as methods for producing the same TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2019-05-14 — — US disclosed
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2018-07-12 — — US disclosed
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2018-07-12 — — US disclosed
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2018-07-12 — — US disclosed
WO-2017008826-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME TECHNISCHE UNIVERSITAET BRAUNSCHWEIG (DE) 2017-01-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180194750-A1 NEW INDOLE COMPOUNDS HAVING ANTIPROTOZOAL ACTIVITY AND ITS USE AS WELL AS METHODS FOR PRODUCING THE SAME IDO1, IDO2, INMT MGAM 1572/4885GAA 2354/4885SI 351/4885
US-10287271-B2 Indole compounds having antiprotozoal activity and its use as well as methods for producing the same IDO1, IDO2, INMT MGAM 1618/4885GAA 2635/4885SI 386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback